Literature DB >> 15793676

[Intravenous immunoglobulins in chronic idiopathic myositis].

H Michels1, G-R Burmester, F Buttgereit.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15793676     DOI： 10.1007/s00393-005-0695-7

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN： 0340-1855            Impact factor:   1.372


× No keyword cloud information.
  83 in total

Review 1.  The epidemiology of virus transmission by plasma derivatives: clinical studies verifying the lack of transmission of hepatitis B and C viruses and HIV type 1.

Authors:  E Tabor
Journal:  Transfusion       Date:  1999 Nov-Dec       Impact factor: 3.157

Review 2.  Polymyositis and dermatomyositis (first of two parts).

Authors:  A Bohan; J B Peter
Journal:  N Engl J Med       Date:  1975-02-13       Impact factor: 91.245

3.  Intravenous immune globulin (IVIG) precipitating acute myocardial infarction.

Authors:  Erika J Struble; Y Gia Dice
Journal:  J Miss State Med Assoc       Date:  2002-04

Review 4.  Polymyositis, dermatomyositis and inclusion-body myositis.

Authors:  M C Dalakas
Journal:  N Engl J Med       Date:  1991-11-21       Impact factor: 91.245

5.  Results and long-term followup of intravenous immunoglobulin infusions in chronic, refractory polymyositis: an open study with thirty-five adult patients.

Authors:  Patrick Cherin; S Pelletier; A Teixeira; P Laforet; T Genereau; A Simon; T Maisonobe; B Eymard; S Herson
Journal:  Arthritis Rheum       Date:  2002-02

6.  Treatment of inclusion-body myositis with high-dose intravenous immunoglobulin.

Authors:  S A Soueidan; M C Dalakas
Journal:  Neurology       Date:  1993-05       Impact factor: 9.910

7.  Acute renal failure associated with immunoglobulin therapy.

Authors:  T G Cantú; E W Hoehn-Saric; K M Burgess; L Racusen; P J Scheel
Journal:  Am J Kidney Dis       Date:  1995-02       Impact factor: 8.860

8.  Hepatitis C virus transmission by intravenous immunoglobulin.

Authors:  P L Yap; F McOmish; A D Webster; L Hammarstrom; C I Smith; J Bjorkander; H D Ochs; S H Fischer; I Quinti; P Simmonds
Journal:  J Hepatol       Date:  1994-09       Impact factor: 25.083

9.  Therapy with intravenous immunoglobulins: complications and side-effects.

Authors:  Matthias Wittstock; Reiner Benecke; Uwe K Zettl
Journal:  Eur Neurol       Date:  2003       Impact factor: 1.710

10.  Incidence of systemic connective tissue diseases in children: a nationwide prospective study in Finland.

Authors:  P M Pelkonen; H J Jalanko; R K Lantto; A L Mäkelä; M A Pietikäinen; H A Savolainen; P M Verronen
Journal:  J Rheumatol       Date:  1994-11       Impact factor: 4.666
View more
  1 in total

1.  [New aspects on the pathogenesis of myositis].

Authors:  B Stuhlmüller; E Feist; T Häupl; G-R Burmester; N Pipitone
Journal:  Z Rheumatol       Date:  2013-04       Impact factor: 1.372
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.